爱全乐气雾剂吸入在慢性阻塞性肺疾病呼吸衰竭的治疗与干预中的效果分析
Treatment and intervention effect of Atrovent aerosol inhalation analysis in patients with chronic obstructive pulmonary disease respiratory failure
祝晓萍 1罗家友1
作者信息
- 1. 湖州市中心医院 呼吸内科,浙江 湖州 313000
- 折叠
摘要
目的 探讨爱全乐气雾剂吸入在慢性阻塞性肺疾病(chronic obstructive pulmonary diseases,COPD)呼吸衰竭的治疗与护理干预中的效果.方法 选择2016年1月~2016年12月于湖州市中心医院诊治的COPD呼吸衰竭患者50例分为对照组和观察组,对照组用常规方式治疗,观察组用常规方式+爱全乐气雾剂吸入治疗;将2组患者各项实验数据作详细记录,并将所获相关数据作对比分析.结果 观察组治疗与干预效果优于对照组,患者临床症状改善情况优于对照组,患者不良反应发生率低于对照组,结果存在统计学差异(P<0.05).结论 COPD呼吸衰竭患者选择常规方式+爱全乐气雾剂吸入治疗效果显著,可有效改善患者临床症状、不良反应少,值得广泛用于治疗COPD呼吸衰竭患者.
Abstract
Objective To investigate the effects of Atrovent aerosol inhalation in the treatment of respiratory failure and nursing intervention of chronic obstructive pulmonary disease effect. Methods January 2016 to December 2016 in Huzhou Central Hospital for diagnosis and treatment of chronic obstructive pulmonary disease patients with respiratory failure in 50 cases dewided into control group and observationgroup: the control group treated with conventional methods, the observation group treated with Atrovent aerosol inhalation therapy and conventional methods; the patients in the two groups of experimental data were recorded in detail, and the obtained data were analyzed. Results The observation group was better than that of treatment and intervention control group, clinical symptoms improved better than the control group, the adverse reaction rate were lower than the control group, there is significant statistical difference (P<0.05). Conclusion The patients with chronic obstructive pulmonary disease with respiratory failure choose conventional and Atrovent aerosol inhalation treatment effect significantly, can effectively improve the patient clinical symptoms and adverse reactions are few and deserve to be widely used in the treatment of chronic obstructive pulmonary diseaseand respiratory failure patients.
关键词
爱全乐气雾剂/慢性阻塞性肺疾病/护理干预Key words
Atrovent aerosol/chronic obstructive pulmonary disease/nursing intervention引用本文复制引用
出版年
2017
NETL
NSTL
维普
万方数据